Clinical Trials Browser

Phase 1/2 × Neoplasms × rilotumumab × Clear all

NCT00770848 2014-03-10

AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer

Phase 1/2 Completed

Neoplasms, Prostatic Neoplasms